Lymphedema following taxane-based chemotherapy in women with early breast cancer

Lymphatic Research and Biology

Volumn 12, Issue 4, 2014, Pages 282-288

  Lee, Mi Joung ^a   Beith, Jane ^b   Ward, Leigh ^a,c   Kilbreath, Sharon ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Chris O Brien Lifehouse   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; ARM CIRCUMFERENCE; ARM EDEMA; ARM PAIN; ARM SWELLING; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; DRUG WITHDRAWAL; EARLY CANCER; FEMALE; GENERALIZED EDEMA; HUMAN; INTRACELLULAR FLUID; LONGITUDINAL STUDY; LYMPHEDEMA; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PATIENT ASSESSMENT; PERIPHERAL EDEMA; ARM; AUSTRALIA; BREAST NEOPLASMS; CANCER STAGING; CHEMICALLY INDUCED; FOLLOW UP; INCIDENCE; MIDDLE AGED; PAIN; PATHOLOGY; PROGNOSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARM; AUSTRALIA; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPHEDEMA; MIDDLE AGED; NEOPLASM STAGING; PAIN; PROGNOSIS;

EID: 84918516582     PISSN: 15396851     EISSN: 15578585     Source Type: Journal    
DOI: 10.1089/lrb.2014.0030     Document Type: Article

References (33)

1. Martin M, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP, Weaver C, tomiak E, Al-Tweigeri T, Chap L, Juhos E, Guevin R, Howell A, Fornander T, Hainsworth J, Coleman R, Vinholes J, Modiano M, Pinter T, Tang SC, Colwell B, Prady C, Provencher L, Walde D, Rodriguez-Lescure A, Hugh J, Loret C, Rupin M, Blitz S, Jacobs P, Murawsky M, Riva A, Vogel C, Breast Cancer International Research Group 001 Investigators. Adjuvant docetaxel for nodepositive breast cancer. N Engl J Med 2005;352:2302-2313
2. Gartner R, Jensen MB, Kronborg L, Ewertz M, Kehlet H, Kroman N. Self-reported arm-lymphedema and functional impairment after breast cancer treatment. A nationwide study of prevalence and associated factors. Breast 2010; 19:506-515
3. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: A meta-Analysis of treatment factors. Ann Surg Oncol 2009;16:1959-1972
4. Ohsumi S, Shimozuma K, Ohashi Y, Takeuchi A, Suemasu K, Kuranami M, Ohno S, Watanabe T. Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02. Oncology 2012;82: 131-138
5. Ravdin PM, Valero V. Review of docetaxel (Taxotere), a highly active new agent for the treatment of metastatic breast cancer. Semin Oncol 1995;22:17-21
6. Vignes S, Lebrun-Vignes B. Sclerodermiform aspect of arm lymphoedema after treatment with docetaxel for breast cancer. J Eur Acad Dermatol Venereol 2007;21:1131-1133
7. Behar A, Pujade-Lauraine E, Maurel A, Brun MD, Chauvin FF, Feuilhade De Chauvin F, Oulid-Aissa D, Hille D. The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication. Br J Clin Pharmacol 1997;43:653-658
8. Jones SE, Erban J, Overmoyer B, Budd GT, Hutchins L, Lower E, Laufman L, Sundaram S, Urba WJ, Pritchard KI, Mennel R, Richards D, Olsen S, Meyers ML, Ravdin PM. Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol 2005; 23:5542-5551
9. Bronstad A, Berg A, Reed RK. Effects of the taxanes paclitaxel and docetaxel on edema formation and interstitial fluid pressure. Am J Physiol Heart Circ Physiol 2004;287: H963-968
10. Qin YY, Li H, Guo XJ, Ye XF, Wei X, Zhou YH, Zhang XJ, Wang C, Qian W, Lu J, He J. Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: A meta-Analysis of 19 randomized trials with 30698 patients. PLoS One 2011;6:e26946.
11. Rockson SG. The unique biology of lymphatic edema. Lymphat Res Biol 2009;7:97-100
12. Cornish BH, Chapman M, Hirst C, Mirolo B, Bunce IH, Ward LC, Thomas BJ. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 2001;34:2-11
13. Ward LC, Kilbreath S, Cornish BH. Bioimpedance analysis for early detection of lymphedema. In: Weissieder H, Schuchhardt C, editors. Lymphedema: Diagnosis and Therapy. 4th ed. Essen: Viavital Verlag Gmbh Publ; 2008. pp. 502-517
14. Kilbreath SL, Refshauge KM, Ward LC, Kastanias K, Yee J, Koelmeyer LA, Beith JM, French JR, Ung OA, Black D. Factors affecting the preoperative and postoperative extracellular fluid in the arm on the side of breast cancer: A cohort study. Lymphat Res Biol 2013;11:66-71
15. Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer 2005;13:904-911
16. Czerniec SA, Ward LC, Refshauge KM, Beith J, Lee MJ, York S, Kilbreath SL. Assessment of breast cancer-related arm lymphedema-Comparison of physical measurement methods and self-report. Cancer Invest 2010;28:54-62
17. Cornish BH, Jacobs A, Thomas BJ, Ward LC. Optimizing electrode sites for segmental bioimpedance measurements. Physiol Meas 1999;20:241-250
18. Domholdt E. Rehabilitation Research: Principles and Applications: Saunders; 2005
19. Ahmed RL, Schmitz KH, Prizment AE, Folsom AR. Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study. Breast Cancer Res Treat 2011;130: 981-991
20. Kwan ML, Darbinian J, Schmitz KH, Citron R, Partee P, Kutner SE, Kushi LH. Risk factors for lymphedema in a prospective breast cancer survivorship study: The Pathways Study. Arch Surg 2010;145:1055-1063
21. Swenson KK, Nissen MJ, Leach JW, Post-White J. Casecontrol study to evaluate predictors of lymphedema after breast cancer surgery. Oncol Nurs Forum 2009;36:185-193
22. Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, Potashnik SL, Miller LT, Fox KR, DeMichele A, Solin LJ. Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev 2010;19:2734-2746
23. Kilbreath SL, Lee MJ, Refshauge KM, Beith JM, Ward LC, Simpson JM. Transient swelling versus lymphoedema in the first year following surgery for breast cancer. Support Care Cancer 2013;21:2207-2215
24. Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010;102:111-118
25. Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Lee M, Simpson JM, Hansen R. Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: A randomized controlled trial. Breast Cancer Res Treat 2012;133:667-676
26. Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Holzel D. Predictors of quality of life of breast cancer patients. Acta Oncol. [Research Support, Non-U.S. Gov't]. 2003;42:710-718
27. Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer-related lymphedema. Mayo Clinic Proc 2005;80:1480-1484
28. Hayes SC, Battistutta D, Parker AW, Hirst C, Newman B. Assessing task "burden" of daily activities requiring upper body function among women following breast cancer treatment. Support Care Cancer 2005;13:255-265
29. Armer JM. The problem of post-breast cancer lymphedema: Impact and measurement issues. Cancer Invest 2005; 23:76-83
30. Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 2008;112:2809-2819
31. Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JK, Lane K, Yasui Y, McKenzie DC. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: A multicenter randomized controlled trial. J Clin Oncol 2007;25:4396-4404
32. Peat JK, Mellis C, Williams K, Xuan W. Health Science Research: A Handbook of Quantitative Methods. Crows Nest, N.S.W.: Allen & Unwin; 2001
33. Ohsumi S, Shimosuma K, Ohashi Y, Takeuchi A, Suemasu K, Kuranami M. Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The national surgical adjuvant study of breast cancer. Oncology 2012;82:131-138